Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shanthi Sivendran

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Oncolytic Virotherapy|August 12, 2016
Oncolytic virus therapy for cancerJoe Goldufsky, Shanthi Sivendran, Sara Harcharik, et al.
Targeted Oncology|July 16, 2013
Pulmonary complications with the use of mTOR inhibitors in targeted cancer therapy: a systematic review and meta-analysisBenjamin A Gartrell, Jian Ying, Shanthi Sivendran, et al.
CA: a Cancer Journal for Clinicians|November 3, 2025
CA turns 75: Looking at the future but never forgetting the rootsDon S Dizon, Sumanta Kumar Pal, Banu E Symington, et al.
BMJ Open|March 24, 2023
Behavioural economic interventions to embed palliative care in community oncology (BE-EPIC): study protocol for the BE-EPIC randomised controlled trialRavi B Parikh, Ramy Sedhom, William J Ferrell, et al.
Journal of the American Academy of Dermatology|April 5, 2014
Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanomaSara Harcharik, Sebastian Bernardo, Marina Moskalenko, et al.
The Journal of Investigative Dermatology|February 14, 2014
Dissection of immune gene networks in primary melanoma tumors critical for antitumor surveillance of patients with stage II-III resectable diseaseShanthi Sivendran, Rui Chang, Lisa Pham, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Oncolytic Virotherapy|August 12, 2016
Oncolytic virus therapy for cancerJoe Goldufsky, Shanthi Sivendran, Sara Harcharik, et al.
Targeted Oncology|July 16, 2013
Pulmonary complications with the use of mTOR inhibitors in targeted cancer therapy: a systematic review and meta-analysisBenjamin A Gartrell, Jian Ying, Shanthi Sivendran, et al.
CA: a Cancer Journal for Clinicians|November 3, 2025
CA turns 75: Looking at the future but never forgetting the rootsDon S Dizon, Sumanta Kumar Pal, Banu E Symington, et al.
BMJ Open|March 24, 2023
Behavioural economic interventions to embed palliative care in community oncology (BE-EPIC): study protocol for the BE-EPIC randomised controlled trialRavi B Parikh, Ramy Sedhom, William J Ferrell, et al.
Journal of the American Academy of Dermatology|April 5, 2014
Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanomaSara Harcharik, Sebastian Bernardo, Marina Moskalenko, et al.
The Journal of Investigative Dermatology|February 14, 2014
Dissection of immune gene networks in primary melanoma tumors critical for antitumor surveillance of patients with stage II-III resectable diseaseShanthi Sivendran, Rui Chang, Lisa Pham, et al.
Pageof 3